特一药业 (002728)

TEYI PHARMACEUTICAL GROUP CO.,LTD

ASZ

Tags

Nicotinamide Mononucleotide (NMN) ConceptMedical Aesthetics ConceptPharmaceutical ManufacturingFund Exclusive HoldingsSmall Cap Non-FinancialHelicobacter PyloriHepatitis Concept

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 51266.19
  • Circulating A-Shares(W): 37647.37
  • Earnings Per Share(RMB): 0.1300
  • Net Assets Per Share(RMB): 3.5168
  • Operating Revenue(W RMB): 69185.06
  • Total Profit(W RMB): 7483.27
  • Net Profit Attributable to Parent(W RMB): 6521.71
  • Net Profit Growth Rate(%): 985.18
  • Weighted Return on Equity(%): 3.6500
  • Operating Cash Flow Per Share(RMB): 0.3730
  • Undistributed Profit Per Share(RMB): 0.7681
  • Capital Reserve Per Share(RMB): 1.6546

2. Main Business

The main business covers:

  • Research, production and sales of Chinese patent medicines
  • Research, production and sales of chemical preparation drugs
  • Research, production and sales of chemical raw materials

3. Company Basic Information

  • Company Name: Teyi Pharmaceutical Group Co., Ltd.
  • Listing Date: 2014-07-31
  • Industry: Pharmaceutical Manufacturing
  • Address: No. 9, 11 Changxing Road, Taicheng, Taishan City, Guangdong Province, China
  • Website: www.tczy.com.cn
  • Company Profile：The company was established by the overall change of Taicheng Co., Ltd. into a joint stock company. The promoters were 24 natural persons including Xu Danqing, Xu Weigao, Xu Songqing, Xu Hengqing, Xu Lifang, Zhao Ruisheng and Chen Xiliang. The company converted the total audited net assets of Taicheng Co., Ltd. as of April 30, 2009, amounting to 86,119,500.9 yuan, into 69 million shares. The balance of 17,119,500.9 yuan was recorded as capital reserve. The company completed the industrial and commercial change registration at the Jiangmen Administration for Industry and Commerce on June 24, 2009, and obtained the "Business License of Enterprise Legal Person" with registration number 440781000013044, with a registered capital of 69 million yuan.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Xingquan CSI 800 Six-Month Holding Index Enhanced Securities Investment Fund Class A Fund 333.38 0.89
2 Xingquan CSI 300 Index Enhanced Securities Investment Fund (LOF) Class A Fund 192.02 0.51
3 Hong Kong Securities Clearing Company Ltd. Northbound Capital 136.96 0.36

5. Concept Sectors

  • Medical Aesthetics Concept
  • NMN Concept
  • Helicobacter Pylori Concept
  • Hepatitis Concept
  • Fund Exclusive
  • Recently Weak
  • Small Cap Non-Margin

Remarks

  • Data update date: 2026-01-01
  • Data source: Public Market Information